NEW YORK (GenomeWeb) – Meridian Bioscience said today that its fiscal third quarter revenues increased 2 percent year over year on strong sales in its Diagnostics unit.

For the third quarter ended June 30, Cincinnati, Ohio-based Meridian posted net revenues of $48.2 million compared to $47.2 million in the year ago quarter and falling shy of analysts' consensus estimate of $48.6 million. Excluding a negative foreign currency effect of approximately $1.5 million, revenues grew 5 percent, Meridian said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.